Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

MA Financial Group (MAF.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-02-16	8.43	-	No Rating
2022-12-16	4.65	6.50	Buy
2023-02-24	4.86	6.60	Buy
2023-11-13	4.78	6.10	Buy
2024-02-23	4.42	5.60	Buy
2024-04-23	4.69	5.70	Buy
2024-08-23	5.15	6.00	Buy
2024-10-23	6.41	7.20	Buy
2025-02-21	8.25	9.20	Buy
2025-04-14	6.47	8.90	Buy

Disclosures

Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.